Updates in Diabetes, Obesity, Preventive Cardiology, and Advanced Lipidology

Updates in Diabetes, Obesity, Preventive Cardiology, and Advanced Lipidology is organized by Continuing Education, Inc. and will be held from Oct 27 - Nov 03, 2020 at Amadeus Star, Budapest, Hungary.

Target Audience:
Physicians, Physician Assistants, Pharmacists, Nurses, Nurse Practitioners

Accreditation:
• 12 AMA PRA Category 1 Credits™
• 12 ACPE Credits
• Up to 12 (part II) MOC points in medical knowledge in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
• 12.0 Contact Hours

Topics:
• Update on diabetes therapies that improve cardiovascular outcomes, Review new approaches to diabetes care
? Review cardiovascular outcomes data for currently available diabetes medications including review of new classes of agents, GLP-1 agonists, SGT2 inhibitors, Quick release bromocriptine.

• Obesity management from the perspective of a lipidologist: root causes analysis and treatment options
? Identify medical factors, medications, insulin resistance as secondary causes of obesity and how to work up, address and treat these conditions.
? Discussion of currently available obesity medications and impact on cardiovascular markers.

• Updates in lipid management:
? Review LDL lowering therapies including PSCK 9 inhibitors and cardiovascular outcomes data, Role of hyperabsorption and treatment options.

• Advanced biomarker testing:
? How to use Apo B, LDL P, Lp (a), inflammatory markers in both primary and secondary prevention.
? Review of the evidence for use of biomarkers in clinical risk assessment and management.

• Case studies:
? Complex lipid management, learn how to manage the most difficult cases.

• Lowering triglycerides and raising HDL Cholesterol, does it matter?
? Review of trial data for niacin, omega 3 fatty acids, fibrates

• Microbiome and cardiovascular disease
? Review of role of gut health and cardiovascular disease and diabetes.
? How to practically assess gut health, TMAO and other gut health markers.

• Women and cardiovascular health throughout the lifetime
? Management of cardiovascular risk throughout lifetime.
? PCOS, menopause, child bearing age. Role of inflammation, MTHFR. 

Additional details will be posted as soon as information is available.